Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma

References

Page 1

	Year	Citations
Oxford Textbook of Medicine. Annals of Internal Medicine Humanity And MedicineImmunohematologySixth EditionEngineeringCell Pathology	1988	1.6K
Pheochromocytoma: recommendations for clinical practice from the First International Symposium Karel Pacák, Graeme Eisenhofer, Håkan Ahlman, Nature Clinical Practice Endocrinology &#38 Metabolism UrologyNeuroendocrine DisorderPathologyEndocrine SurgeryClinical Practice	2007	676
Oxford textbook of medicine Alan E H Emery Neuromuscular Disorders Humanity And MedicinePhilosophy Of MedicineMedical EthicsMedical HistoryMedicine	1997	448
Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma C. PRYS‐ROBERTS, John R. Farndon World Journal of Surgery	2002	182
Preoperative pharmacological management of phaeochromocytoma. Anouk N.A. van der Horst‐Schrivers, M. N. Kerstens, Bruce H. R. Wolffenbuttel University of Groningen research database (University of Groningen / Centre for Information Technology)	2006	75
The alpha 1‐adrenoceptor antagonist profile of doxazosin: preclinical pharmacology. Alabaster Va, M. K. Davey British Journal of Clinical Pharmacology	1986	65
Prazosin and propranolol in preoperative management of pheochromocytoma Luigi X. Cubeddu, Nixie A Zarate, Carlos B Rosales, Clinical Pharmacology & Therapeutics	1982	48
Clinical pharmacological studies with doxazosin. HL Elliott, PA Meredith, John Vincent, British Journal of Clinical Pharmacology HypertensionHeart FailureClinical Pharmacological StudiesAgingCardiovascular Pharmacology	1986	44
Doxazosin: A newly developed, selective α1-inhibitor in the management of patients with pheochromocytoma Yukio Miura, Kaoru Yoshinaga American Heart Journal Malignant Blood DisorderHematologyPharmacologyPathologySelective α1-Inhibitor	1988	29

Page 1